Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review

Applied Health Economics and Health Policy

Volumn 14, Issue 4, 2016, Pages 409-418

  Raymakers, Adam J N ^a,e   Mayo, John ^a   Lam, Stephen ^a,b   FitzGerald, J Mark ^a   Whitehurst, David G T ^c,d   Lynd, Larry D ^a,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

^d VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^e ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMBASE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MEDLINE; OUTCOME ASSESSMENT; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; RADIATION DOSE; REVIEW; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; HEALTH SERVICE; LUNG NEOPLASMS; PROCEDURES; RISK ASSESSMENT; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; X-RAY COMPUTED TOMOGRAPHY;

COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MEDICAL OVERUSE; QUALITY-ADJUSTED LIFE YEARS; RADIATION DOSAGE; RISK ASSESSMENT; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84957939497     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-016-0226-5     Document Type: Review

References (45)

1. Stewart BW, International Agency for Research on Cancer, World Health Organization. World cancer report 2014. Lyon: International Agency for Research in Cancer; 2014.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
3. Coleman M, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–38.
4. Team National Lung Screening Trial Research, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.
5. Moyer VA. Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;160(5):330–8.
6. Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013. Available at: http://www.ncbi.nlm.nih.gov/books/NBK154610/. Accessed 24 Mar 2015
7. Centers for Medicare and Medicaid Services (CMS). Proposed decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). 2014. Available at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed 24 Mar 2015.
8. Goulart BHL, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Cancer Netw. 2012;10(2):267–75.
9. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press; 2005.
10. Organization for Economic Co-Operation and Development. Purchasing power parities and exchange rates. Available at: http://stats.oecd.org/Index.aspx?DataSetCode=SNA_TABLE4. Accessed 23 Mar 2015.
11. United States Bureau of Labour Statistics. Consumer Price Index (CPI). Available at: http://www.bls.gov/cpi/cpid1502.pdf. Accessed 23 Mar 2015.
12. Raymakers AJN, Mayo J, Marra CA, FitzGerald M. Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: a systematic review of cost-effectiveness analyses. J Thorac Imaging. 2014;29(4):209–16.
13. Beinfeld MT, Wittenberg E, Gazelle GS. Cost-effectiveness of whole-body CT screening. Radiology. 2005;234(2):415–22.
14. Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, et al. Cost-effectiveness of CT screening in the national lung screening trial. N Engl J Med. 2014;371(19):1793–802.
15. Chirikos TN, Hazelton T, Tockman M, Clark R. Cost-effectiveness of screening for lung cancer. JAMA. 2003;289(18):2358.
16. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. J Am Med Assoc. 2003;289(3):313–22.
17. Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer. 2005;48(2):171–85.
18. Marshall D, Simpson KN, Earle CC, Chu CW. Economic decision analysis model of screening for lung cancer. Eur J Cancer. 2001;37(14):1759–67.
19. Marshall D, Simpson KN, Earle CC, Chu C. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer. 2001;32(3):227–36.
20. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6(11):1841–8.
21. Okamoto N. Cost-effectiveness of lung cancer screening in Japan. Cancer. 2000;89(11 Suppl):2489–93.
22. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood). 2012;31(4):770–9.
23. Pyenson BS, Henschke CI, Yankelevitz DF, Yip R, Dec E. Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis. Am Health Drug Benefits. 2014;7(5):272–81.
24. Shmueli A, Fraifeld S, Peretz T, Gutfeld O, Gips M, Sosna J, et al. Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience. Value Health. 2013;16(6):922–31.
25. Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One. 2013;8(8):e71379.
26. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007;56(1):125–34.
27. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369(10):920–31.
28. NICE. The social care guidance manual. Incorporating economic evaluation. Guidance and guidelines. Available at: http://www.nice.org.uk/article/pmg10/chapter/incorporating-economic-evaluation#measuring-and-valuing-effects. Accessed 8 Apr 2015.
29. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies Canada. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2006. Available at: https://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf. Accessed 8 Apr 2015.
30. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making. 2006;26(4):391–400.
31. Earle CC, Chapman RH, Baker CS, Bell CM, Stone PW, Sandberg EA, et al. Systematic overview of cost-utility assessments in oncology. J Clin Oncol. 2000;18(18):3302–17.
32. Manser R. Screening for lung cancer: a review. Curr Opin Pulm Med. 2004;10(4):266–71.
33. Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, et al. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess. 2006;10(3):iii–iv, ix–x, 1–90.
34. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14(4):339–47.
35. Kucharczyk MJ, Menezes RJ, McGregor A, Paul NS, Roberts HC. Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J. 2011;62(2):141–5.
36. Galbán CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–5.
37. Polonsky TS. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303(16):1610.
38. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728–36.
39. Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014;11(12):e1001764.
40. Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 2014;15(12):1332–41.
41. Henschke CI. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2013;158(4):246.
42. Lam S, McWilliams A, Mayo J, Tammemagi M. Computed tomography screening for lung cancer: What is a positive screen? Ann Intern Med. 2013;158(4):289–90.
43. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. In: Cochrane Database of Systematic Reviews. Wiley; 1996. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000165.pub3/abstract. Accessed 25 Mar 2015
44. Gomez MM, LoBiondo-Wood G. Lung cancer screening with low-dose CT: its effect on smoking behavior. J Adv Pract Oncol. 2013;4(6):405–14.
45. Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106(6):dju084.